VEITIA Reiner A. : UMR7592 : Molecular Oncology and ovarian Pathologies

Unit : CNRS UMR7592 - Institut Jacques Monod - Université Paris Diderot

Université Paris Diderot
Institut Jacques Monod - CNRS UMR7592
Bâtiment Buffon
15 Rue Hélène Brion
75013 PARIS 

Speciality : Department DGNRV

Director of the unit : Giuseppe BALDACCI

Principal investigator :

VEITIA Reiner A.
Email : veitia.reinerSPAMFILTER@ijm.univ-paris-diderot.fr Phone number: +33 (0)1 57 27 81 16

Composition of research team :

  • VEITIA Reiner (PR1, HDR)
  • CABURET Sandrine  (MCF)
  • PENRAD-MOBAYED May (CR1-CNRS, HDR)
  • TODESCHINI Anne-Laure (MCF)
  • VANET Anne (MCF)
  • ZIDER Alain (PR1, HDR)

5 Recent publications of the research team :

Caburet S, Arboleda VA, Llano E, Overbeek PA, Barbero JL, Oka K, Harrison W, Vaiman D, Ben-Neriah Z, García-Tuñón I, Fellous M, Pendás AM, Veitia RA, Vilain E. (2014). Mutant cohesin in premature ovarian failure.  N Engl J Med. 2014 Mar 6;370(10):943-9.

Gibson TJ, Seiler M, Veitia RA.(2013). The transience of transient overexpression. Nature Methods. 2013 Aug;10(8):715-21.

Benayoun BA, Anttonen M, L'Hôte D, Bailly-Bechet M, Andersson N, Heikinheimo M, Veitia RA.(2013). Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation. Oncogene. 2013 May 30;32(22):2739-46

L'Hôte D, Georges A, Todeschini AL, Kim JH, Benayoun BA, Bae J, Veitia RA.(2012). Discovery of novel protein partners of the transcription factor FOXL2 provides insights into its physiopathological roles. Hum Mol Genet. 2012 Jul 15;21(14):3264-74.

 

Todeschini AL, Dipietromaria A, L'hôte D, Boucham FZ, Georges AB, Pandaranayaka PJ, Krishnaswamy S, Rivals I, Bazin C, Veitia RA.Mutational probing of the forkhead domain of the transcription factor FOXL2 provides insights into the pathogenicity of naturally occurring mutations. Hum Mol Genet. 2011 Sep 1;20(17):3376-85.